Cite
HARVARD Citation
Stieglitz, E. et al. (n.d.). Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer. 62 (4), pp. 629-636. [Online].